Rivaroxaban - an oral, direct Factor Xa inhibitor - has potential for the management of patients with heparin-induced thrombocytopenia

Title
Rivaroxaban - an oral, direct Factor Xa inhibitor - has potential for the management of patients with heparin-induced thrombocytopenia
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 143, Issue 1, Pages 92-99
Publisher
Wiley
Online
2008-07-31
DOI
10.1111/j.1365-2141.2008.07300.x

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation